STAT+: FDA gives a mixed response to a petition seeking greater clinical trial transparency
The U.S. Food and Drug Administration told an advocacy group that it is not planning…
Category: Medicine
.jpg)
Humira’s legacy, CEO symbolism, and genomic surgery
What do CEOs owe the world? Did Humira break the system? And can you CRISPR…
Embryo loss is integral to IVF. Alabama’s ruling equating embryos to children jeopardizes its practice
An embryo is one of the earliest stages of development of a multicellular organism. But…
STAT+: San Diego biotech Neurocrine Biosciences joins PhRMA
WASHINGTON — Neurocrine Biosciences, a biotech company based in California, has joined the drug lobbying…
.jpg)
Opinion: The Alabama IVF ruling uses faux scientific language to justify a religious position
Imagine having 15 miscarriages. Maybe you can shrug off the first one or two and…
STAT+: DOJ investigating Community Health Systems’ hospitals
Community Health Systems is facing a new federal probe into its hospital billing practices more…
Colorado could cap payments for Amgen’s Enbrel
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Florida policy set amid measles outbreak alarms vaccination proponents
A Florida state policy set amid a measles outbreak in Broward County has vaccination proponents…
Novavax’s money is going in the wrong direction
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about India-made versions of Wegovy, an RSV vaccine scramble, and more
Top of the morning to you, and a fine one it is. Clear blue skies…
STAT+: Novavax and Gavi end a bitter dispute over Covid-19 vaccines with a refund up to $400 million
After a contentious dispute, Novavax has agreed to refund up to $400 million to the…
War zone or not, Ukraine seeks to reclaim its role as a hub for clinical trials
In the years leading up to Russia’s invasion, Ukraine had become a burgeoning hub of…
Opinion: How to make after-hours primary care better for doctors — and patients
One of us, Jeffrey M., is on weekend call for our office-based internal medicine practice….
Presidential age debate obscures a simple fact: Some cognitive skills improve as we get older
When a psychology professor in Michigan looked through his data on interpersonal conflict a decade…
Alabama hospital pauses IVF treatments in wake of ruling saying frozen embryos are children
MONTGOMERY, Ala. — A large Alabama hospital paused in vitro fertilization treatments Wednesday as health…
Small study adds to growing hope CAR-T cell therapy could revolutionize autoimmune disease treatment
People with autoimmune disorders don’t usually get to talk about a cure. There’s symptom management,…
STAT+: Scientists take a (small) step toward universal antivenom
Antivenom, like Mexican Coke or grandma’s cookies, is still made the old-fashioned way. In antivenom’s…
STAT+: Pharmalittle: We’re reading about a CEO change at AbbVie, a long-acting HIV drug, and more
Rise and shine, everyone. The middle of the week is upon us. Have heart, though….
Actually Wegovy is good for dialysis companies, dialysis provider says
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: DarioHealth acquires Twill, hoping it’s a shortcut to profitability
DarioHealth, which makes apps for managing chronic diseases, today announced it will acquire digital mental…
NIH study of ME/CFS points to immune dysfunction and brain abnormalities at core of long-dismissed disease
Alison Sbrana was in the belly of an opera when her life changed. Down in…
Watch: What is in utero gene editing?
Recently approved gene therapies offer patients one-time, potentially curative treatments for genetic diseases such as…
Opinion: How Medicare leaves Puerto Ricans behind
When I accompany my father to his regular cardiologist appointment in Puerto Rico, worry and…
Meet the fetal surgeon forging CRISPR’s next frontier: curing diseases in the womb
SAN FRANCISCO — Outside, the August sun wasn’t yet visible through the thick folds of…
STAT+: Hospitals race to adopt generative AI, even as regulators struggle to keep up with the risks
Usually the words generative AI in health are followed by a bold claim. The technology…
STAT+: Ring Therapeutics, a gene therapy startup, lays off 20% of staff
Ring Therapeutics, a gene therapy startup launched by Flagship Pioneering, has laid off just under…
Should ACA plans cover weight loss drugs?
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Medicare Advantage’s 33 million club
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…
STAT+: FDA warns medical device makers about rise in fabricated data
An increasing number of medical device companies are submitting fabricated and unreliable data, the Food…
STAT+: AbbVie CEO Gonzalez to step down after a decade fiercely defending its top seller, Humira
AbbVie announced Tuesday that CEO Richard Gonzalez, who has managed the company’s ascent since it…
Bayer, short on cash, reaches into shareholders’ pockets
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about weight loss drugs, a cell therapy for melanoma, and more
Good morning, everyone, and welcome to another working week, which is getting off to a…
STAT+: A lawsuit over a controversial Sanofi drug shortage is unexpectedly revived
A U.S. appeals court revived a controversial lawsuit brought by nearly two dozen people who…
Phage therapy: Researchers sharpen another arrow in the quiver against antibiotic resistance
Lynn Cole was in a never-ending cycle of getting recurrent blood infections. And no antibiotic…
STAT+: As regulators play catch up with AI, tech startups say uncertainty is slowing them down
The federal government’s plan to boost its oversight of the use of artificial intelligence tools…
STAT+: Obamacare plans don’t have to cover weight loss drugs. The government is considering changing that
WASHINGTON — Drugmakers are doing everything to tap the bottomless well of demand for new…
Opinion: New CMS rules will throttle access researchers need to Medicare, Medicaid data
Groundbreaking research more than a decade ago showed that almost one-fifth of people enrolled in…
‘All of Us’ reports half of the genomes it has sequenced are from non-Europeans
Six years ago, the National Institutes of Health placed its biggest ever bet on precision…
Niacin has long been a public health darling. But an excess could be bad for the heart, study suggests
Niacin, or vitamin B3, has long been a U.S. public health darling to the point…
Opinion: The complicated connections between weight loss drugs and mental health
Mental illness can cause or worsen obesity, and obesity can cause or worsen mental illness….
STAT+: Opioid cravings were reduced by anti-obesity drug in small study
DENVER — The GLP-1 medication liraglutide significantly reduced opioid cravings in a small analysis presented on…
Opinion: STAT readers on what human health care can learn from veterinary medicine and more
STAT now publishes selected Letters to the Editor received in response to First Opinion essays…
STAT+: Leading MD Anderson oncologist disputes junior scientist’s claims in lawsuit over research credit
Prominent immunologist and oncologist Padmanee Sharma defended herself in court on Friday against a lawsuit…
STAT+: In ‘major milestone,’ FDA approves first cell therapy for solid tumors
Nearly four decades after its first conception, the first TIL therapy, an immunotherapy that harvests…
STAT+: Banning surprise medical bills is raising costs elsewhere
Without question, the new federal law banning surprise billing is achieving its goal of protecting…
Key congressman blasts HHS for lack of cooperation on Covid-19
The Health and Human Services Department’s lack of cooperation with a congressional committee investigating the…
STAT+: Flagship Pioneering startup lays off a third of staff
Sonata Therapeutics, a startup created two years ago through the merger of two Flagship Pioneering…
STAT+: Medicare Advantage enrollment races past 33 million
Roughly 33.4 million adults older than 65 and people with disabilities were enrolled in a…
STAT+: Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech
CAMBRIDGE, Mass. — The increasingly adversarial relationship between the United States and China has raised…
More people die after smoking drugs than injecting them, study finds
NEW YORK — Smoking has surpassed injecting as the most common way of taking drugs…